CooperVision has a long history of bringing innovation to our contact lenses and overcoming technical problems like difficult fittings. We take our position as a leading global contact lens manufacturer with a sense of pride, encouraging us to make even more advancements in the field of ocular science.
Buttressing this determination is our strong R&D team.
Currently, we have over 30 PhDs helping us in research and development. This occurs in Pleasanton, CA, Southampton, U.K., and Nobeoka, Japan. In each of these cities, our raw material analysis, combined with our process engineering, come together to yield the excellent clinical performance we demand in each of our contacts.
A small sampling of our advancements includes:
Aquaform® Technology - Our Aquaform technology provides a naturally wettable material that establishes hydrogen bonds with water molecules; this holds water within the lens helping make the lens wettable without the need for surface treatments or wetting agents. Oxygen is transmitted efficiently through the lens due to unique silicone macros that provide long chains of silicone. This unique silicone macromer features a reduced number of molecular bridges, making it softer and more flexible than older first generation silicone hydrogel lenses.
This exciting technology is only available through CooperVision in our Avaira® and Biofinity® families of contact lenses.
PC Technology™ – Simply put, our PC Technology helps our Proclear® contacts stay 96% hydrated throughout the day, helping them feel moist and comfortable. In fact, our Proclear contacts are the only lens material cleared by the U.S. FDA for the claim: “May provide improved comfort for contact lens wearers who experience mild discomfort or symptoms relating to dryness during lens wear.”
As we said, this is just a small sampling of what we have done to advance the field of contact lenses and bring more comfort and benefits to both wearers and optometrists alike.
Are we striving to bring even more advancements in the world of contact lenses? Of course! Stay tuned for more announcements from CooperVision.